aluminum hydroxide 50.8 MG/ML / magnesium carbonate 47.5 MG/ML [Gaviscon]
RxNorm concept 576423, branded drug component (sbdc).
- RxCUI
- 576423
- Term type
- Branded drug component (SBDC)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/576423 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Related concepts
- aluminum hydroxide 50.8 MG/ML / magnesium carbonate 47.5 MG/ML Oral Suspension [Gaviscon] (SBD, constitutes)
- Gaviscon (BN, has ingredient)
- aluminum hydroxide 50.8 MG/ML (SCDC, tradename of)
- magnesium carbonate 47.5 MG/ML (SCDC, tradename of)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 576423 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/576423 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 576423. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.